Discuss the potential of Medical Value Tourism in India. How do recent visa reforms and the 'Heal in India' initiative address its constraints?

Medical Value Tourism (MVT) means foreigners travelling to India for treatment, often combined with wellness and AYUSH care. In 2024 it brought 6,44,387 foreign patients, about 6.48% of all foreign tourist arrivals [1]. The potential is large. Realising it needs easier entry and a wider base of source countries.

Potential of MVT

• Integrative care: India is positioning itself as an MVT hub that combines clinical care with AYUSH and wellness [3].
• Economic driver: The Union Budget 2025-26 named medical tourism a growth driver for tourism-linked jobs and services [6].
• Diverse demand: After Bangladesh, the next largest source is Iraq, which points to untapped West Asian demand [2].
• Soft power: AYUSH-based treatment carries Indian traditional medicine to patients abroad [5].

Constraints

• Incomplete recovery: Arrivals in 2024 were still below the 6,97,453 recorded in 2019 [1].
• Narrow source base: Bangladesh sent 4,82,336 patients in 2024, about three in four. Total medical arrivals fell to 5,07,244 in 2025 [2].
• Data deficit: The Ministry of Tourism has not assessed the sector's status, challenges or growth potential [2].
• Complex entry: Overlapping visa categories made it hard for applicants to choose the right visa [4].

How visa reforms address them

• Simplification: In 2026 MHA cut main visa categories from 13 to 9 and application form fields by 65–70% [4].
• Staged treatment: M-1 (conventional) and M-3 (AYUSH) visas, with the attendant visas M-2 and M-4, are granted for one year with multiple entry by default [4].
• Short visits: The V-1 Visitor Visa covers medical consultations and wellness retreats [4].
• Reach: The e-Medical visa is open to nationals of 172 countries [3].

How 'Heal in India' addresses them

• Branding AYUSH: The Ministry of AYUSH signed an MoU with ITDC to promote AYUSH-based medical value travel [5].
• Private partnership: Budget 2025-26 proposed promoting Heal in India together with the private sector [6].
• Residual gap: Visas remove barriers but do not create patients. When one neighbour supplies most patients, relations with that country count for more than visa design [2].

Together, purpose-based visas and Heal in India make entry easier and give India's integrative care a brand. Next steps: diversify towards Africa and West Asia, publish purpose-wise arrival data, and build a single-window patient portal. This would make MVT a lasting pillar of SDG 3 (health) and SDG 8 (decent work), in keeping with India's ethos of Sarve Santu Niramayah.